BSN medical acquires lymphoedema garment maker JoViPak
September 23, 2015 - Germany
BSN medical, a global leader in wound care and related vascular diseases, lymphology and non-invasive orthopaedic products, has bought JoViPak, a manufacturer of lymphoedema garments.
The acquisition complements BSN’s comprehensive product portfolio designed for the management of lymphatic disorders, and allows the company to cater to the underserved, yet rapidly growing market of lymphoedema management during the day and night-time. BSN’s acquisition of JoViPak is an attractive complement to the recently announced acquisition of FarrowMed, which provides BSN with the patented FarrowWrap compression wrap used to manage lymphoedema.
Dr Guido Oelkers, CEO of BSN medical GmbH said, “We are very proud to welcome JoViPak to the BSN family. Their team has successfully created unique and high-quality products, and they have built an excellent reputation in the market. This acquisition further complements our comprehensive portfolio of lymphoedema solutions. JoViPak’s exceptional night care portfolio is a perfect addition to the JOBST, Elvarex, and FarrowWrap brands offered by BSN, and further enhances our ability to provide best-in-class therapeutic solutions to the patients living with lymphoedema day and night.”
JoViPak has built its reputation on producing high-quality lymphoedema management garments for the treatment of both acute and chronic oedema. JoViPak will be integrated into BSN’s wound care and vascular franchise while its operations will remain in Seattle, according to a press release.
JoAnn Rovig, president and CEO of JoViPak said, “Being afflicted with lymphoedema myself, I created JoViPak out of compassion for and an understanding of patients. We are very proud that JoViPak has developed into a premier provider of high-quality lymphoedema products. The lymphoedema treatment market still lacks awareness, and the combination of BSN and JoViPak is a tremendous opportunity to not only offer patients a comprehensive treatment solution with garments for day and night-time use, but also to raise awareness of the disease.”
With the addition of JoViPak, BSN will be able to address the custom and ready-to-wear night-time garment market used to manage lymphoedema symptoms. As a result of the acquisition, BSN will benefit from an increased market presence in the US. BSN’s global footprint and sales network will make JoViPak’s products available to even more patients all around the world. (GK)
The acquisition complements BSN’s comprehensive product portfolio designed for the management of lymphatic disorders, and allows the company to cater to the underserved, yet rapidly growing market of lymphoedema management during the day and night-time. BSN’s acquisition of JoViPak is an attractive complement to the recently announced acquisition of FarrowMed, which provides BSN with the patented FarrowWrap compression wrap used to manage lymphoedema.
Dr Guido Oelkers, CEO of BSN medical GmbH said, “We are very proud to welcome JoViPak to the BSN family. Their team has successfully created unique and high-quality products, and they have built an excellent reputation in the market. This acquisition further complements our comprehensive portfolio of lymphoedema solutions. JoViPak’s exceptional night care portfolio is a perfect addition to the JOBST, Elvarex, and FarrowWrap brands offered by BSN, and further enhances our ability to provide best-in-class therapeutic solutions to the patients living with lymphoedema day and night.”
JoViPak has built its reputation on producing high-quality lymphoedema management garments for the treatment of both acute and chronic oedema. JoViPak will be integrated into BSN’s wound care and vascular franchise while its operations will remain in Seattle, according to a press release.
JoAnn Rovig, president and CEO of JoViPak said, “Being afflicted with lymphoedema myself, I created JoViPak out of compassion for and an understanding of patients. We are very proud that JoViPak has developed into a premier provider of high-quality lymphoedema products. The lymphoedema treatment market still lacks awareness, and the combination of BSN and JoViPak is a tremendous opportunity to not only offer patients a comprehensive treatment solution with garments for day and night-time use, but also to raise awareness of the disease.”
With the addition of JoViPak, BSN will be able to address the custom and ready-to-wear night-time garment market used to manage lymphoedema symptoms. As a result of the acquisition, BSN will benefit from an increased market presence in the US. BSN’s global footprint and sales network will make JoViPak’s products available to even more patients all around the world. (GK)